600329.SS
600329.SS
CNE000001808
TIANJIN PHARMACEUTICAL DA REN T
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
27.57B EUR
28.66B EUR
31.5B EUR
35.13B EUR
Enterprise Value
24.13B EUR
26.3B EUR
30.65B EUR
34.18B EUR
Valuation Multiples
Trailing P/E
32.25x
45.96x
16.1x
18.43x
Forward P/E
19.78x
--
--
--
Price to Sales
5.84x
7.74x
7.96x
9.01x
Price to Book
4.64x
4.82x
4.19x
4.95x
EV/Revenue
5.11x
7.11x
7.74x
8.77x
EV/EBITDA
22.68x
28.68x
12.35x
14.23x
Price to FCF (P/FCF)
18.71x
46.86x
93.97x
134.64x
EV/FCF
16.38x
43x
91.45x
131x
FCF Yield
5.34%
2.13%
1.06%
0.74%
ende